Jenburkt Pharmaceuticals Limited (BOM:524731)
India flag India · Delayed Price · Currency is INR
999.95
+1.95 (0.20%)
At close: Mar 4, 2026

Jenburkt Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
4,4134,4653,0432,9392,6011,828
Market Cap Growth
-6.53%46.74%3.52%13.02%42.23%25.34%
Enterprise Value
4,3343,7092,4882,4742,1491,172
Last Close Price
1000.00998.56668.58633.75526.89363.00
PE Ratio
13.6113.9311.7111.9511.6611.08
PS Ratio
2.672.942.142.152.101.67
PB Ratio
2.412.602.102.402.221.86
P/TBV Ratio
2.422.602.112.402.221.87
P/FCF Ratio
-54.5054.6319.6641.839.99
P/OCF Ratio
-16.0037.4617.2428.059.40
EV/Sales Ratio
2.622.441.751.811.731.07
EV/EBITDA Ratio
10.809.337.678.288.046.15
EV/EBIT Ratio
11.639.848.088.788.456.58
EV/FCF Ratio
-45.2844.6816.5534.566.40
Debt / Equity Ratio
0.010.02-0.020.060.05
Debt / EBITDA Ratio
0.040.10-0.100.250.26
Debt / FCF Ratio
-0.48-0.201.090.28
Net Debt / Equity Ratio
-0.04-0.11-0.51-0.38-0.34-0.48
Net Debt / EBITDA Ratio
-0.20-0.48-2.28-1.56-1.49-2.46
Net Debt / FCF Ratio
--2.35-13.28-3.11-6.41-2.56
Asset Turnover
-0.840.930.960.940.97
Inventory Turnover
-3.533.713.713.673.32
Quick Ratio
-2.396.014.483.003.91
Current Ratio
-3.006.705.153.574.45
Return on Equity (ROE)
-20.25%19.43%20.52%20.66%18.49%
Return on Assets (ROA)
-13.04%12.54%12.37%12.04%9.87%
Return on Invested Capital (ROIC)
15.47%24.19%30.98%27.52%29.42%33.06%
Return on Capital Employed (ROCE)
-21.20%20.70%22.40%20.90%17.30%
Earnings Yield
7.35%7.18%8.54%8.37%8.57%9.03%
FCF Yield
-1.84%1.83%5.08%2.39%10.01%
Dividend Yield
1.80%1.80%2.29%2.27%2.28%2.81%
Payout Ratio
-21.15%24.32%22.35%20.99%-
Buyback Yield / Dilution
-0.00%-3.34%0.52%--
Total Shareholder Return
1.80%1.80%5.63%2.79%2.28%2.81%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.